首页> 外文期刊>Strahlentherapie und Onkologie >Localization and quantification of the delivered dose to the spinal cord: Predicting actual delivered dose during daily MVCT image-guided tomotherapy
【24h】

Localization and quantification of the delivered dose to the spinal cord: Predicting actual delivered dose during daily MVCT image-guided tomotherapy

机译:脊髓给药剂量的定位和量化:预测每日MVCT图像引导的Tomotherapy期间的实际给药剂量

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: The goal of the present work was to localize and quantify the actual delivered dose to the cervical spinal cord (SC) during head and neck cancer (H&N) treatment. Materials and methods: A total of 20 H&N patients treated with bilateral nodal irradiation with helical tomotherapy (HT) were analyzed. Daily MVCTs were performed for image guidance. On every second MVCT, the SC was recontoured and the delivered dose for the given treatment fraction (12 fractions per patient) was recalculated. The magnitude and localization (CT slice, spinal cord quadrant) of the Dmax to the SC on the planning CT (PLAN-Dmax) and of the actual delivered Dmax (a-Dmax) were analyzed. Results: A systematic deviation from the PLAN-Dmax was observed in 15 out of 20 patients. Large interpatient variability of the a-Dmax in the spinal cord was noted (4.5 ± 4 %). Intrapatient variability in a-Dmax was, generally, minimal (1.8 ± 2.7 %). Throughout the treatment course, the higher dose was located in the same CT slices and in the same quadrants (anterior right and anterior left) for the same patient. Conclusion: Exact localization and quantification of the change of the a-Dmax can be made for most patients by recalculating the dose on the daily IGRT-MVCTs. This could be helpful in assessing whether replanning is necessary in patients with doses close to the known tolerance doses of the spinal cord.
机译:目的:本研究的目的是定位和量化头颈癌(H&N)治疗期间向颈脊髓(SC)输送的实际剂量。材料和方法:分析了总共20例H&N患者,这些患者均接受了双侧淋巴结螺旋线照射(HT)照射。每日进行MVCT,以进行图像指导。在每第二个MVCT上,重新设计SC轮廓,并重新计算给定治疗分数(每位患者12个分数)的输送剂量。分析了计划CT上Dmax到SC的大小和位置(CT切片,脊髓象限)(PLAN-Dmax)和实际交付的Dmax(a-Dmax)。结果:20名患者中有15名与PLAN-Dmax有系统性偏差。注意到患者中脊髓中a-Dmax的较大差异(4.5±4%)。通常,患者的a-Dmax变异很小(1.8±2.7%)。在整个治疗过程中,对于同一位患者,较高的剂量位于相同的CT切片和相同的象限(右前和左前)中。结论:通过重新计算每日IGRT-MVCT的剂量,可以对大多数患者进行a-Dmax变化的精确定位和定量。这可能有助于评估剂量是否接近脊髓已知耐受剂量的患者是否需要重新计划。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号